409
CONCLUSIONS: This case report showed that the clinical appearance of Hashimoto's disease after IFN-alpha therapy for chronic C hepatitis in our patient was associated with a specific genetic predisposition (DR5) for this pathology.
 our patient: Subject; a specific genetic predisposition (DR5) for this pathology: Subject.Disorder; clinical appearance of Hashimoto's disease: Effect; IFN-alpha: Treatment; chronic C hepatitis: Treatment.Disorder; IFN-alpha: Treatment.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 our patient: Subject; a specific genetic predisposition (DR5) for this pathology: Subject.Disorder; clinical appearance of Hashimoto's disease: Effect; IFN-alpha: Treatment; chronic C hepatitis: Treatment.Disorder; IFN-alpha: Treatment.Drug